Qizheng Tibetan Medicine: Promoting Tibetan Medicine’s External Therapies to Help Traditional Medicine Enter the International Market

　　Recently, at the Harvard Traditional Chinese Medicine Forum hosted by the Massachusetts Association of Chinese Medicine in the U.S., Qizheng Tibetan Medicine (002287) introduced to over 100 local healthcare professionals China’s first batch of Intangible Cultural Heritage—“Tibetan Medical External Therapies”—receiving an enthusiastic response.

　　According to Chen Weiwu, General Manager of the Qizheng Tibetan Medicine R&D Center and Director of the Institute for External Treatment of Traditional Tibetan Medicine, Tibetan medicine boasts a long history spanning 2,300 years and is underpinned by numerous classic medical texts and theoretical works. In the Tibetan medical text "The Four Medical Tantras," the causes and mechanisms of disease in the human body are categorized into "Lung," "Chikba," and "Beden." The therapeutic principle lies precisely in restoring balance among these three "substances" to bring the body back into equilibrium. External treatment methods are one of the four fundamental therapeutic approaches in Tibetan medicine. When drug therapy fails to produce significant effects, or when certain specific diseases require external treatments—or necessitate combined internal and external therapies—external treatment methods become indispensable. Throughout history, the theoretical foundation of Tibetan external treatments has primarily drawn from the "External Treatment" section of "The Four Medical Tantras." These external treatment methods include five main techniques: bloodletting, moxibustion, hot and cold compresses, medicinal baths, and topical applications, all of which rely on Tibetan medicine's unique herbal remedies and medical devices. As an example, Chen Weiwu also introduced the academic research conducted by the scientific community on the efficacy mechanisms of Qizheng Tibetan Medicine’s pain-relieving plaster. Thanks to its distinctive analgesic and anti-inflammatory action mechanism and its patented moist-application formulation, this pain-relieving plaster achieves remarkable pain-relief effects.

　　The audience at the scene showed great interest in Tibetan medicine. Many attendees remarked that they had previously known very little about the traditional medicines of China’s ethnic minorities. They emphasized that Tibetan medicine is a wonderful complement to traditional Chinese medicine and an essential part of promoting Chinese culture that should not be overlooked. Ziga Cangzhen, a Tibetan-Chinese individual, said that he has been familiar with Tibetan medicine since childhood and expressed his delight and pride that the Tibetan heritage is now being preserved and is making its way onto the global stage.

　　It is reported that since 2013, Qizheng Tibetan Medicine has been collaborating with Professor David Christiani of Harvard University, an internationally renowned expert in occupational disease research, to establish the Harvard Tibetan Medicine Research Laboratory. The laboratory focuses on the role and expansion of Tibetan medicine in addressing major diseases from a global perspective, and explores the clinical value of classic Tibetan medicines within the framework of modern integrative medicine.

　　Liu Kaili, Vice President of the China Association for Ethnic Medicine and President of Qizheng Tibetan Medicine, stated that currently, the internationalization of Traditional Chinese Medicine (TCM) is primarily driven by traditional TCM practices such as acupuncture; the degree of internationalization of ethnic medicines, however, remains far from sufficient. As Qizheng Tibetan Medicine seeks to expand into the U.S. market, its first step is to promote the traditional culture of Tibetan medicine, break down cultural barriers, and enhance consumers’ awareness and understanding of Tibetan medicine.

　　Due to the stringent and time-consuming approval process for oral medications in the United States, and given that mainstream medicine places great emphasis on oral drugs and surgical procedures, acupuncture-based topical therapies—often unique in their approach—have frequently emerged as a breakthrough for the development of traditional Chinese medicine in the U.S. Drawing on the historical development of traditional Chinese medicine, Tibetan medicine’s external treatment methods clearly represent a suitable area for promotion in the United States.

　　Liu Kaili stated that in recent years, China’s efforts to promote the internationalization of traditional Chinese medicine and its growing emphasis on ethnic medicines have provided strong momentum for ethnic medicines to go global. Qizheng Tibetan Medicine hopes to share the wisdom and achievements of ethnic medicine with American consumers. Speaking about the key entry points for promoting Tibetan medicine in the U.S., he believes that efficacy is the real strength. It’s crucial to identify the specific diseases and distinctive therapies where Tibetan medicine excels, enabling patients to clearly see the advantages of Tibetan medical treatments, thereby boosting acceptance and earning positive word-of-mouth.

　　Reporting media: Securities Times

　　Report link: http://company.stcn.com/2017/0816/13562813.shtml